Zhejiang Xianju Pharmaceutical Co., Ltd. announced its resolution to seek shareholder authorization for the Board of Directors to formulate and implement the 2026 interim profit distribution plan. This aims to reward investors and share operational results, with the distribution amount capped by net profit attributable to shareholders. The authorization period is from the 2025 annual general meeting to the 2026 annual general meeting.
Summary generated by AI · Always verify with source document
Securities Code: 002332 Securities Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-008
Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on Seeking Shareholders' Authorization for the Board of Directors to Formulate and Implement the 2026 Interim Profit Distribution Plan
The Company and the entire Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, without any false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.